EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts

Qiming Tan iD, Ye Peng, Edward C Deehan iD, Flavio T Vieira, Brian Wan Ping Ho, Shima Afhami, Eytan Wine iD, Karen L Madsen iD, Catherine J Field, Mohammadreza Pakseresht, Olga Ilkayeva, Christopher B Newgard und 3 weitere

The Journal of Clinical Endocrinology & Metabolism · 16.10.2025 · 110 (11) · 3120-3132

DOI: 10.1210/clinem/dgaf142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.03.2025. Verfasst von Qiming Tan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada T6G 2B7. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, Gastrointestinal Microbiome, Dietary Fiber, Hyperphagia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Weston Family Foundation and Foundation, Canadian Consortium of Clinical Trial Training Platform, Women and Children's Health Research Institute Patient and Community Engagement Training.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

While increased fiber intake may benefit appetite and metabolism in the general population, its effects in individuals with Prader-Willi syndrome (PWS), a condition characterized by hyperphagia, obesity, and metabolic dysregulation, remain to be explored.

Objective

This study assessed the effects of a fiber intervention on hyperphagia, metabolic health, and gut microbiota in individuals with PWS, and explored associations between changes in health markers and shifts in microbiota.

Methods

Participants received either a high-dose fiber intervention (35 g/day) or a control for 3 weeks. Following a washout period of 4 to 8 weeks, participants switched treatments for another 3 weeks. Fecal (bacterial 16S ribosomal RNA) and blood (immunometabolic markers, targeted metabolomics) samples were collected before and after each treatment.

Results

Fourteen participants (with a median age of 13.6 years, 8 [57.1%] were female) reported high tolerance to the fiber intervention. While it did not significantly alter hyperphagia or key metabolic markers, the fiber intervention led to shifts in gut microbiota diversity and increased the abundance of beneficial bacteria, such as Bifidobacterium longum and Faecalibacterium prausnitzii. Additionally, it altered fecal and serum metabolites, including a decrease in branched-chain fatty acids and an increase in serum C4-OH acylcarnitine.

Conclusion

While this study did not observe significant changes in primary or secondary endpoints, it suggests that a short-term high-fiber intervention may induce beneficial shifts in gut microbiota and microbial metabolites in individuals with PWS. Further research is warranted to investigate the long-term effects and potential therapeutic applications of fiber interventions in PWS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prader-Willi SyndromeGastrointestinal MicrobiomeDietary FiberHyperphagiaHumansFemaleMaleAdolescentFecesChildYoung AdultAdultBiomarkers

Stichwörter der Autor:innen

Prader-Willi syndromedietary fibergut microbiotahyperphagiametabolic health

Substanzen

Dietary FiberBiomarkers

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada T6G 2B7.
  • Microbiota I-Center (MagIC), Hong Kong SAR, 999077, China.
  • JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.
  • Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, 999077, China.
  • Department of Food Science and Technology, University of Nebraska, Lincoln, NE 68588, USA.
  • Nebraska Food for Health Center, Food Science & Technology, Lincoln, NE 68588, USA.

ORCID-Profile: Qiming Tan, Edward C Deehan, Eytan Wine, Karen L Madsen, Jens Walter, Andrea M Haqq

Förderung

  • Weston Family Foundation and Foundation
  • Canadian Consortium of Clinical Trial Training Platform
  • Women and Children's Health Research Institute Patient and Community Engagement Training
  • Helmholtz International School
  • Alberta Diabetes Institute Graduate
  • InnoHK, The Government of Hong Kong, Special Administrative Region of the People's Republic of China
  • Chinese University of Hong Kong

Zitieren

APA

Tan, Q., Peng, Y., Deehan, E. C., Vieira, F. T., Ho, B. W. P., Afhami, S., Wine, E., Madsen, K. L., Field, C. J., Pakseresht, M., Ilkayeva, O., Newgard, C. B., Walter, J., Tun, H. M., & Haqq, A. M. (2025). Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts. The Journal of Clinical Endocrinology & Metabolism, 110(11), 3120-3132. https://doi.org/10.1210/clinem/dgaf142

Vancouver

Tan Q, Peng Y, Deehan EC, Vieira FT, Ho BWP, Afhami S, et al. Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts. The Journal of Clinical Endocrinology & Metabolism. 2025;110(11):3120-3132. doi:10.1210/clinem/dgaf142

BibTeX
@article{Tan2025,
  author = {Tan, Qiming and Peng, Ye and Deehan, Edward C and Vieira, Flavio T and Ho, Brian Wan Ping and Afhami, Shima and Wine, Eytan and Madsen, Karen L and Field, Catherine J and Pakseresht, Mohammadreza and Ilkayeva, Olga and Newgard, Christopher B and Walter, Jens and Tun, Hein Min and Haqq, Andrea M},
  title = {Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {11},
  pages = {3120--3132},
  doi = {10.1210/clinem/dgaf142}
}
Kostenlos starten →